xanomeline has been researched along with scopolamine hydrobromide in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bonifazi, A; Del Bello, F; Farande, A; Ferré, S; Matucci, R; Nesi, M; Petrelli, R; Piergentili, A; Quaglia, W; Vistoli, G; Yano, H | 1 |
| Abou-Gharbia, M; Bartolomeo, AC; Boast, CA; Buccafusco, JJ; Husbands, MG; Kille, N; Morris, H; Moyer, JA; Rosenzweig-Lipson, S; Sabb, AL | 1 |
| Nathaniel, TI; Olajuyigbe, F; Umesiri, FE | 1 |
| Caine, SB; Fink-Jensen, A; Fulton, BS; Thomsen, M; Wess, J | 1 |
| Barak, S; Weiner, I | 1 |
| Hikichi, H; Maehara, S; Ohta, H | 1 |
| Kimura, H; Kurimoto, E; Nakashima, M; Suzuki, M | 1 |
7 other study(ies) available for xanomeline and scopolamine hydrobromide
| Article | Year |
|---|---|
Synthesis and biological evaluation of a novel series of heterobivalent muscarinic ligands based on xanomeline and 1-[3-(4-butylpiperidin-1-yl)propyl]-1,2,3,4-tetrahydroquinolin-2-one (77-LH-28-1).
Topics: Animals; CHO Cells; Cricetulus; Molecular Docking Simulation; Muscarinic Agonists; Piperidines; Pyridines; Quinolones; Receptor, Muscarinic M1; Structure-Activity Relationship; Thiadiazoles | 2014 |
The preclinical pharmacological profile of WAY-132983, a potent M1 preferring agonist.
Topics: Animals; Aziridines; Behavior, Animal; Brain; Bridged-Ring Compounds; Choline; Choline O-Acetyltransferase; Cognition; Dose-Response Relationship, Drug; Drug Interactions; Female; Frontal Lobe; Hippocampus; Hypothermia; Macaca mulatta; Male; Mice; Muscarinic Agonists; Neuromuscular Blocking Agents; Pyrazines; Pyridines; Rats; Rats, Sprague-Dawley; Salivation; Scopolamine; Thiadiazoles; Time Factors; Visual Cortex | 2000 |
Role of M1 receptor in the locomotion behavior of the African mole-rat (Cryptomys sp).
Topics: Analysis of Variance; Animals; Behavior, Animal; Dose-Response Relationship, Drug; Locomotion; Mole Rats; Muscarinic Agonists; Muscarinic Antagonists; Pyridines; Receptor, Muscarinic M1; Scopolamine; Thiadiazoles; Time Factors | 2008 |
Modulation of prepulse inhibition through both M(1) and M (4) muscarinic receptors in mice.
Topics: Animals; Antipsychotic Agents; Behavior, Animal; Clozapine; Female; Haloperidol; Male; Mice; Mice, Knockout; Muscarinic Agonists; Muscarinic Antagonists; Oxotremorine; Pyridines; Receptor, Muscarinic M1; Receptor, Muscarinic M4; Reflex, Startle; Scopolamine; Thiadiazoles | 2010 |
The M₁/M₄ preferring agonist xanomeline reverses amphetamine-, MK801- and scopolamine-induced abnormalities of latent inhibition: putative efficacy against positive, negative and cognitive symptoms in schizophrenia.
Topics: Amphetamine; Animals; Antimanic Agents; Behavior, Animal; Cognition Disorders; Dizocilpine Maleate; Dose-Response Relationship, Drug; Kinetics; Male; Molecular Targeted Therapy; Muscarinic Agonists; Neural Inhibition; Neurotransmitter Agents; Pyridines; Rats; Rats, Wistar; Receptor, Muscarinic M1; Receptor, Muscarinic M4; Receptors, N-Methyl-D-Aspartate; Schizophrenia; Scopolamine; Tachyphylaxis; Thiadiazoles | 2011 |
Behavioral effects of N-desmethylclozapine on locomotor activity and sensorimotor gating function in mice-Possible involvement of muscarinic receptors.
Topics: Acoustic Stimulation; Animals; Antipsychotic Agents; Clozapine; Dose-Response Relationship, Drug; Drug Interactions; Mice; Motor Activity; Muscarinic Agonists; Neural Inhibition; Oxotremorine; Psychophysics; Pyridines; Receptors, Muscarinic; Scopolamine; Sensory Gating; Thiadiazoles | 2011 |
TAK-071, a muscarinic M1 receptor positive allosteric modulator, attenuates scopolamine-induced quantitative electroencephalogram power spectral changes in cynomolgus monkeys.
Topics: Allosteric Regulation; Alpha Rhythm; Animals; Delta Rhythm; Donepezil; Dose-Response Relationship, Drug; Electroencephalography; Macaca fascicularis; Muscarinic Agonists; Pyridines; Receptor, Muscarinic M1; Scopolamine; Theta Rhythm; Thiadiazoles | 2019 |